Seung-Ho Kim
Corporate Officer/Principal chez BORYUNG CORPORATION
Profil
Seung-Ho Kim currently works at Boryung Corp., as Chairman-Executive Board from 2014 and Boryung Holdings Co., Ltd., as Director from 2012.
Mr. Kim also formerly worked at MEDIENCE Co., Ltd., as Chairman-Executive Board.
Mr. Kim received his graduate degree from Korea University.
Postes actifs de Seung-Ho Kim
| Sociétés | Poste | Début |
|---|---|---|
| BORYUNG CORPORATION | Corporate Officer/Principal | 19/05/2014 |
Boryung Holdings Co., Ltd.
 Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Directeur/Membre du Conseil | 01/03/2012 |
Anciens postes connus de Seung-Ho Kim
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIENCE CO., LTD. | Président | 31/03/2014 |
Formation de Seung-Ho Kim
| Korea University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BORYUNG CORPORATION | Health Technology |
| MEDIENCE CO., LTD. | Consumer Non-Durables |
| Entreprise privées | 1 |
|---|---|
Boryung Holdings Co., Ltd.
Boryung Holdings Co., Ltd. BiotechnologyHealth Technology Boryung Holdings Co., Ltd. engages in the provision of real estate leasing and distributing technologies for remedial medicines. Its products are used in remedies for hyperlipidemia and Tamsulosin for prostatic hypertrophy. The company was founded on May 5, 1990 and is headquartered in Seoul, South Korea. | Health Technology |